The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Scoop: Gilead out­lines plans to mus­cle up its man­u­fac­tur­ing arm af­ter Im­munomedics lay­offs

4 years ago
Pharma

FDA res­ur­rects pro­pos­al to gauge qual­i­ty met­rics in phar­ma man­u­fac­tur­ing

4 years ago
FDA+

Sanofi CEO Paul Hud­son sketch­es a $1B-plus in­vest­ment on its new mR­NA cen­ter

4 years ago
Pharma

Am­gen gets the dirt fly­ing on its new $550M man­u­fac­tur­ing site as phar­ma build­ing booms in NC

4 years ago
Pharma

With in­vest­ment from Al­loy, Boston pep­tide man­u­fac­tur­er an­nounces Se­ries A

4 years ago
Financing
Pharma

Af­ter near­ly two years of crit­i­cism from ac­tivists and White House, Mod­er­na un­veils a new plan for glob­al health

4 years ago
Coronavirus

Months af­ter big fi­nanc­ing round, Touch­light signs sup­ply agree­ment for Ver­same­b's pipeline

4 years ago
Pharma

Kenya wins $500M sweep­stakes for Mod­er­na's first African man­u­fac­tur­ing site

4 years ago
Pharma

'Re­call ready': FDA urges com­pa­nies to com­ply with drug re­call guid­ance

4 years ago

In Ger­man-on­ly an­nounce­ment, Bay­er in­vests $1.5B in­to na­tive coun­try man­u­fac­tur­ing

4 years ago

NASEM re­leas­es re­port on med­ical sup­ply-chain re­silien­cy

4 years ago

Af­ter 25 years, Hov­ione's CEO will step down; Helsinn gains in­fi­gra­tinib li­cense from Bridge­Bio 

4 years ago

Covid-19 man­u­fac­tur­ing roundup: 9 part­ners to help Bio­vac's man­u­fac­tur­ing ex­pan­sion; Af­ter pro­duc­tion pledges, Covid-19 test de­mand has plum­met­ed

4 years ago

Catal­ent ex­pands in­hala­tion ef­forts in col­lab­o­ra­tion with Texas-based phar­ma

4 years ago
Pharma

Ster­ling builds up its API ca­pac­i­ty with big buy of No­var­tis cam­pus in Ire­land

4 years ago
Pharma

Months af­ter IPO, Ital­ian vial com­pa­ny lands BAR­DA in­vest­ment as gov­ern­ment looks to shore up pan­dem­ic pre­pared­ness

4 years ago

No­vavax dou­bles down on promise to pro­duce 2B Nu­vax­ovid dos­es — this year

4 years ago
R&D
Pharma

Cure­Vac es­tab­lish­es RNA print­er-spe­cif­ic com­pa­ny as light at the end of tun­nel nears

4 years ago
Pharma

Emer­gen­t's trou­bled Bal­ti­more site gets $100M up­grade

4 years ago
Pharma

On a roll, Re­ci­pharm wraps up its sec­ond and third CD­MO ac­qui­si­tions this month

4 years ago
Pharma

Covid-19 man­u­fac­tur­ing roundup: Scot­tish gov­ern­ment in­vests $27M in Val­neva's Covid-19 man­u­fac­tur­ing; Mod­er­na part­ners with Latin Amer­i­can phar­ma

4 years ago

Mod­er­na ties the knot with Ther­mo Fish­er on a 15-year man­u­fac­tur­ing al­liance, glu­ing a glob­al net­work

4 years ago

Build­ing on CRISPR suc­cess, In­tel­lia inks deal for new man­u­fac­tur­ing fa­cil­i­ty in Waltham, MA

4 years ago
Pharma
Cell/Gene Tx

Man­u­fac­tur­ing re­org at Mer­ck KGaA in­spires a $500M+ in­vest­ment in mR­NA tech

4 years ago
Pharma
First page Previous page 56575859606162 Next page Last page
A service from the Financial Times